NetworkNewsBreaks – EVIO, Inc. (EVIO) Testing Se
Post# of 2022
EVIO, Inc. (OTCQB: EVIO), a life sciences and cannabis testing company, continues to thrive in the flourishing cannabis industry. An article discussing the company reads: “Cannabis testing services like those offered by EVIO currently comprise about five percent of the total marijuana market, which is projected to reach $31.4 billion globally by 2021 (http://nnw.fm/BGR2g). Ancillary services to the cannabis market make an attractive investment opportunity that is considered more reliable in many ways than investing in the plant directly. EVIO’s offerings further add the inducement that cannabis testing is mandatory and will continue to be so, making this particular segment of the industry a solid one that boasts longevity, predictability and sustainability. The market for cannabis testing is, for these reasons and others, one of the most enticing for investors within the legal marijuana space.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer